439 related articles for article (PubMed ID: 28877720)
21. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
Ben-Aharon I; Granot T; Meizner I; Hasky N; Tobar A; Rizel S; Yerushalmi R; Ben-Haroush A; Fisch B; Stemmer SM
Oncologist; 2015 Sep; 20(9):985-91. PubMed ID: 26099742
[TBL] [Abstract][Full Text] [Related]
23. Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma.
Policiano C; Subirá J; Aguilar A; Monzó S; Iniesta I; Rubio Rubio JM
J Assist Reprod Genet; 2020 Jul; 37(7):1755-1761. PubMed ID: 32488563
[TBL] [Abstract][Full Text] [Related]
24. Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report.
Kim HJ; Noh WC; Nam SJ; Park BW; Lee ES; Im SA; Jung YS; Yoon JH; Kang SS; Park KH; Lee SJ; Jeong J; Lee MH; Cho SH; Kim SY; Kim HA; Han SH; Han W; Hur MH; Kim S; Ahn SH
Eur J Cancer; 2021 Jul; 151():190-200. PubMed ID: 34010788
[TBL] [Abstract][Full Text] [Related]
25. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study.
Czuczwar P; Stepniak A; Milart P; Paszkowski T; Wozniak S
J Ovarian Res; 2018 Jun; 11(1):45. PubMed ID: 29859107
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
[TBL] [Abstract][Full Text] [Related]
28. Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer.
Perdrix A; Saint-Ghislain M; Degremont M; David M; Khaznadar Z; Loeb A; Leheurteur M; Di Fiore F; Clatot F
Reprod Biomed Online; 2017 Oct; 35(4):468-474. PubMed ID: 28652099
[TBL] [Abstract][Full Text] [Related]
29. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
[TBL] [Abstract][Full Text] [Related]
30. The effect of isotretinoin on ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with acne.
Aksoy H; Cinar L; Acmaz G; Aksoy U; Aydin T; Vurdem UE; Oz L; Idem Karadag O; Kartal D
Gynecol Obstet Invest; 2015; 79(2):78-82. PubMed ID: 25660129
[TBL] [Abstract][Full Text] [Related]
31. Intake of soy products and soy isoflavones in relation to ovarian reserve.
Mitsunami M; Mínguez-Alarcón L; Florio AA; Wang S; Attaman JA; Souter I; Hauser R; Chavarro JE;
Fertil Steril; 2023 Jun; 119(6):1017-1029. PubMed ID: 36871859
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G; Navarro PA; Oktay K
Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
[TBL] [Abstract][Full Text] [Related]
33. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
34. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
[TBL] [Abstract][Full Text] [Related]
35. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
Sinha N; Letourneau JM; Wald K; Xiong P; Imbar T; Li B; Harris E; Mok-Lin E; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Oct; 35(10):1861-1868. PubMed ID: 30066303
[TBL] [Abstract][Full Text] [Related]
36. Effect of cigarette smoking on serum anti-Mullerian hormone and antral follicle count in women seeking fertility treatment: a prospective cross-sectional study.
Bhide P; Timlick E; Kulkarni A; Gudi A; Shah A; Homburg R; Acharya G
BMJ Open; 2022 Mar; 12(3):e049646. PubMed ID: 35361635
[TBL] [Abstract][Full Text] [Related]
37. Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles.
Deb S; Campbell BK; Clewes JS; Pincott-Allen C; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2013 Feb; 41(2):216-22. PubMed ID: 22744915
[TBL] [Abstract][Full Text] [Related]
38. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
[TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
Dezellus A; Barriere P; Campone M; Lemanski C; Vanlemmens L; Mignot L; Delozier T; Levy C; Bendavid C; Debled M; Bachelot T; Jouannaud C; Loustalot C; Mouret-Reynier MA; Gallais-Umbert A; Masson D; Freour T
Eur J Cancer; 2017 Jul; 79():72-80. PubMed ID: 28463758
[TBL] [Abstract][Full Text] [Related]
40. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
